Document Detail


Pisa Syndrome secondary to rivastigmine: a case report.
MedLine Citation:
PMID:  22362231     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Pisa syndrome or pleurothotonus is the persistent flexion of the body and head to one side giving the appearance of the leaning tower of Pisa. It is most commonly caused by typical and atypical antipsychotic drugs. We report a case of Pisa Syndrome caused by prolonged use of high dose cholinesterase inhibitor, rivastigmine. Symptoms subsided when rivastigmine was withdrawn and did not reappear when a different cholinesterase inhibitor, donepezil was introduced. Physicians should be aware of Pisa syndrome and should alert patient of this possibility when starting and stepping up medications. The purpose of reporting this case is to create awareness among general practitioners as it is a reversible condition which responds to removal of the offending drug. Clin Ter 2012; 163(1):31-32.
Authors:
M Leelavathi; R Rosdinom; M Suguna
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  La Clinica terapeutica     Volume:  163     ISSN:  1972-6007     ISO Abbreviation:  Clin Ter     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372604     Medline TA:  Clin Ter     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  31-2     Citation Subset:  IM    
Affiliation:
Department of Family Medicine, Universiti Kebangsaan Malaysia Medical Center, Department of Psychiatry, Universiti Kebangsaan Malaysia Medical Center, Department of Internal Medicine, Selangor Medical Center.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An unique case of thoracic endovascular aortic repair (TEVAR) graft infection with Streptococcus Vir...
Next Document:  Role of rifaximin in the treatment of colonic diverticular disease.